ClinicalTrials.gg
RecruitingNCT07155603VACPUpdated Nov 2, 2026

Visual Aids for Colonoscopy Preparation: A Prospective Study on Patient Understanding and Bowel Cleanliness in Colonoscopy Patients

An interventional study of Animated Video Group 1 in The Effect of Audio-visual Aids on Bowel Cleanliness and Audiovisual Aids, sponsored by Prof. Dr. Jörg Leuppi. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Prof. Dr. Jörg Leuppi · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Updated Nov 2, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Effective communication in healthcare is critical for improving patient outcomes, particularly in enhancing health literacy and enabling informed decision-making. Traditional informed consent for colonoscopy often fails to clearly explain the procedure, risks, and preparation requirements, leading to inadequate bowel preparation, longer procedures, and missed lesions. Standard educational materials like videos and written instructions are often impersonal, lack cultural inclusivity, and fail to engage patients effectively. Emerging tools, such as the multilingual, visually enhanced Meine Behandlung video series from Visikon®, aim to improve patient comprehension and adherence. This study seeks to compare the effectiveness of these animated videos against traditional consent methods in enhancing patient understanding and adherence, particularly for complex procedures like colonoscopy, which is crucial for diagnosing and preventing colorectal cancer.

02

Conditions studied

  • The Effect of Audio-visual Aids on Bowel Cleanliness
  • Audiovisual Aids
03

In context

Lead sponsor

Prof. Dr. Jörg Leuppi is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years or older
  • Scheduled for a routine outpatient colonoscopy procedure
  • Capable of understanding communication in German and willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patients with cognitive impairments
  • Those unwilling to participate
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Traditional Consent (Control Group)

    The traditional informed consent process involves the provision of written documents and verbal explanation to the patient regarding the colonoscopy procedure, risks, and preparation requirements

    Behavioral: Animated Video Group 1

  • Experimental
    Animated Video 1

    Patients of this group will be asked to watch the Visikon animated videos, in addition to receiving standard informed consent

    Behavioral: Animated Video Group 1

Interventions

  • BehavioralAnimated Video Group 1

    The animated video intervention provides a clear and engaging multimedia explanation of the colonoscopy procedure in multiple languages. It includes visual aids to help explain the process, preparation instructions, risks, and expected outcomes, aiming to improve patient comprehension and adherence.

06

What researchers measure

Primary outcomes

  1. Bowel Preperation

    The objective of assessing the primary endpoint the patient's bowel cleanliness, will be measured during the routine colonoscopy, using the Boston Bowel Preperation Scale. The Boston Bowel Preparation Scale (BBPS) is a validated tool used to assess the cleanliness of the colon during a colonoscopy, Each of the three segments of the colon (right, transverse, and left) is assigned a score ranging from 0 to 3, with the following criteria: Total Score 0: The entire colon is unprepared, and no mucosa is visible. Total Score 1-3: Poor preparation, significant portions of the mucosa are not visible. Total Score 4-6: Fair preparation, with some portions of the mucosa visible but others obscured. Total Score 7-9: Good to excellent preparation, with most or all mucosa well visualized. Interpretation Scores of 0-3: Generally considered inadequate for proper assessment and diagnosis, likely requiring repeat preparation and examination. Scores of 4-6: Indicative of suboptimal preparation

    Time frame: 24 months

Secondary outcomes

  1. Patient Health Literacy & Communication Satisfaction

    The secondary outcome seeks to assess the patient's health literacy and general communication satisfaction. This will be done by assessing their answers to the Health Literacy Questionnaire.

    Time frame: 24 months

07

Study locations

1 of 1 sites recruiting
  • Cantonal Hospital of Baselland
    Liestal, 4410, Switzerland
    Recruiting
    • Zahra Pasha · Contactzahra.pasha@ksbl.ch · 0041 61 400 40 40
    • Zahra Pasha, B.A, M.A., TESOL, iPGCE, MCIL · Sub investigator
    • Jörg D Leuppi, M.D, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Feb 2026 (actual). Primary completion is estimated for Aug 2027, 18 months after the start.

Start moved once since we started tracking on Sep 25, 2026: Sep 2025 → Feb 2026, on Nov 2, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 10, 2025
First posted
Sep 4, 2025
StartActual
Feb 5, 2026was Sep 2025
Primary completionEst.
Aug 15, 2027
CompletionEst.
Dec 15, 2028
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 2, 2026
Sites
Cantonal Hospital of Baselland is now Recruiting
Nov 2, 2026
Start date
Sep 2025→Feb 5, 2026 (actual)
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    Not yet recruiting→Recruiting
    Cantonal Hospital of Baselland is now Recruiting
    Start date Sep 2025→Feb 5, 2026 (now actual)
    + 4 other changes: identifiers, verification date, responsible party and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07155603
Lead sponsor
Prof. Dr. Jörg Leuppi
Responsible party
Prof. Dr. Jörg Leuppi (Prof. Dr. med. Jörg Daniel Leuppi, Cantonal Hospital, Baselland) — Sponsor-investigator
First posted
Sep 4, 2025
Start date
Feb 5, 2026
Primary completion
Aug 15, 2027 (estimated)
Completion
Dec 15, 2028 (estimated)
Last update
Nov 2, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion